Showing 1721-1730 of 3305 results for "".
Liquid Nitrogen Cryotherapy Anesthesia for Botulinum Toxin Injections for Hyperhidrosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/liquid-nitrogen-cryotherapy-anesthesia-for-botulinum-toxin-injections-for-hyperhidrosis/23687/An accessible but underutilized technique can increase patient comfort.Jawline Contouring Treatment with Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/jawline-contouring-treatment-with-injectables/23647/Use of injectables can produce jaw-dropping results.How Physicians Are Unlike Most US Investors
https://practicaldermatology.com/topics/practice-management/how-physicians-are-unlike-most-us-investors/23370/A look at how the difference in the tax situations of physicians and average retail investors, and why these differences matter.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-latest-on-galderma-eczema-awareness-hacking-derm-and-more/19675/In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses herEstablishing Incentives for Practice Administrators
https://practicaldermatology.com/topics/practice-management/establishing-incentives-for-practice-administrators/23051/Tips to create a performance-based program that compensates appropriately and motivates the administrator to continue moving the practice forward.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abd-eyes-mohs-certification-sun-s-ilumya-approved-fue-update/18319/The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the MusicalNew Advancements in Microneedle Resurfacing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-advancements-in-microneedle-resurfacing/21354/Microneedle resurfacing has quickly become one of the most in-demand aesthetic procedures, likely due to its strong results, quick healing times, and cost-effectiveness.